Funding

SECTION I: ESTIMATION OF COSTS

 

1

Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result.
… in terms of IPR protection
The PCT patent application has been extended to the US (US13/058581) and Europe (EP2321346).

 

…in terms of product development
 

 

 

 

…in terms of mass production
 

 

 

 

… in terms of marketing
 

 

2

Based on the above assessment as well as the marketing information please provide the correct estimation of thepriceforR&Dproduct in correlation with costs

Year 1

Year 2

Year 3

Year 4

Year 5

Fixed costs

Personnel

Other running costs

Marketing costs

TOTAL EXPECTED COSTS

Price per Unit

Type of Unit

Number of Units

TOTAL Expected Revenues

CASH FLOW REQUIRED (REVENUES-COSTS)

TOTAL CAPITAL required for five years

 

 

SECTION 2: QUALITATIVE FACTORS

 

3

Dimension of identified target groups
Big pharma. → Muscle disorder’s patients

 

 

 

 

 

 

 

4

Evaluation of financial Risks for R&D result
High.

 

 

 

 

 

 

 

 

SECTION 3: IDENTIFICATION OF FINANCING SOURCES

After evaluating all the above mentioned criteria, please tick the best financing source for the achievement of R&D result (i.e. own capitals, banking credits, venture capital, business angels, etc)

 

1. European Funding

Define relevance of the product with the following potential funding sources and comment

  1. 1.  

2.

3.

4.

 

2. National Funding

1.

2.

 

3. Private funding

1. They are looking for research collaborators for preclinical, clinical tests.

2.

3.

 

4. Other

 

SECTION 3: FINAL EVALUATION

It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)…
The invention has needed further research and should be done the preclinical and clinical tests.

 

 

 

 

 

 

 

 

Decision of evaluation (Please keep only the appropriate)

  • The R&D result needs moderate revisions
Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

You must be logged in to post a comment.

Request a proposal

Valorisation Plan Authors

Related Documents

There in no related documents

Visit the other applications of the INTERVALUE Platform: R&D Repository | IP Agreements

© 2009-2010 INTERVALUE Project